NCT00373360View on ClinicalTrials.gov

Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Pulmonary Hypertension
Interventions
DRUG

treprostinil sodium

rapid switch from intravenous epoprostinol to intravenous remodulin on the CADD ambulatory pump

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY